Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Responses of State Medicaid Programs to Buprenorphine Diversion | Synapse

July 24, 2013

Ver artículo completo

Responses of State Medicaid Programs to Buprenorphine Diversion

RCRobin E. ClarkCommunity Healthlink JBJeffrey D. BaxterUniversity of Massachusetts Chan Medical School

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Abuse of prescription opioids is an increasing national concern. Recent reports point to growing rates of overdose, addiction, emergency department visits, and death attributable to nonmedical use of prescription pain medications.1,2

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Clark et al. (Wed,) studied this question.

synapsesocial.com/papers/6a220205c7675eb28596ecd7 https://doi.org/https://doi.org/10.1001/jamainternmed.2013.9059

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Evidence Doesn’t Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine2011 · 85 citations
2Mental and Substance Use Disorders Among Medicaid Recipients: Prevalence Estimates from Two National Surveys2003 · 91 citations
3Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians2011 · 117 citations
4The DAWN report: Emergency department visits involving buprenorphine2012 · 7 citations
5Buprenorphine May Not Be as Safe as You Think: A Pediatric Fatality From Unintentional Exposure2012 · 47 citations